Publications

Publication

Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease

Nalle SC, Kwak HA, Edelblum KL, Joseph NE, Singh G, Khramtsova GF, Mortenson ED, Savage PA, Turner JR. Sci Transl Med 2014. 6, 243ra287. PMC4161673
PDFPUBMED

Jerrold R. Turner, MD, PhD
Professor of Pathology and Medicine

Brigham and
Women's
Hospital

Harvard
Medical
School

TH 613
20 Shattuck St.
Boston, MA 02115.

© Copyright JR Turner 2020.